-+ 0.00%
-+ 0.00%
-+ 0.00%

PTC Therapeutics Director Michael Schmertzler Reports Sale of Common Shares Worth $149,036.84

PUBT·10/16/2026 21:23:08
PTC Therapeutics Director Michael Schmertzler Reports Sale of Common Shares Worth $149,036.84
  • PTC Therapeutics director Michael Schmertzler sold 2,500 common shares through indirect holdings on October 14, 2026.
  • Sales comprised 2,118 shares at $59.52 per share and 382 shares at $60.14 per share.
  • Following the transactions, Schmertzler held 1,291,594 shares indirectly and 163,266 shares directly.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PTC Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001288952-26-000016), on October 16, 2026, and is solely responsible for the information contained therein.